Ortho-Clinical Diagnostics Plans Vitros Fusion Analyzer 510(k) By 2002
This article was originally published in The Gray Sheet
Ortho-Clinical Diagnostics expects to submit a 510(k) for the Vitros 5,1 FS (Fusion series) in vitro diagnostic instrument by the end of this year, with a launch anticipated in early 2003.
You may also be interested in...
The three names under consideration also have a history of focusing on helping underprivileged communities get access to health care.
With operations in the MENA region already tracking to $700m in revenues for 2020, Hikma is looking to grow the business further after beginning negotiations with GSK to buy certain of the originator’s businesses in Egypt and Tunisia.
A safety study of Pfizer's anchor immunology brand Xeljanz showed higher rates of heart attacks and cancer versus a TNF inhibitor.